Introduction
Gastric carcinoma has been divided into two major histologic types: well differentiated (intestinal, expanding, differentiated, and glandular) and poorly differentiated (diffuse, infiltrating, undifferentiated, and nonglandular) [1] [2] [3] [4] . The former is characterized by expansive growth and hematogenous metastasis to the liver, and the latter by infiltrating growth and peritoneal dissemination. Among well differentiated gastric carcinomas, a tumor consisting of papillary structures with columnar epithelium is called a papillary adenocarcinoma [5] . This histologic subtype is rare, and its biological behavior and prognostic significance are unclear.
The aim of this study was to clarify the following: (1) the clinicopathologic features of papillary gastric carcinoma (PGC) compared with those of non-papillary gastric carcinoma (NGC); (2) the difference in 5-year survival rates and causes of tumor-related deaths in patients with PGC compared with patients with NGC; and (3) the clinicopathologic factors influencing the prognosis of patients with PGC.
Patients and methods
During the period from January 1982 to July 1998, 631 patients with gastric adenocarcinoma, but no evidence of any other malignancy, underwent gastrectomy at the First Department of Surgery, Oita Medical University. Of the 631 patients, PGC was demonstrated in 65 (10.3%). PGC is composed of papillary epithelial processes with thin fibrous cores (Fig. 1) . We defined PGC as a tumor in which more than 50% of the tumor area contained papillary structures. Of the 65 PGCs, 27 were early gastric carcinomas, and 38 were advanced gastric carcinomas. A tumor was defined as early gastric carcinoma when the invasion was limited to the mucosa or submucosa, and as advanced gastric carcinoma when it invaded the muscularis propria or deeper, regardless of the presence or absence of lymph node metastasis [5] .
The age and sex of the patient, type of operation, location of the tumors, and presence or absence of liver metastasis and peritoneal dissemination were determined from medical charts. Gross appearance was examined using photographs of the resected specimens, and tumor size was given as the maximal diameter. All specimens were fixed in a 10% formalin solution and cut along the largest diameter of the tumor or along its deepest invasion. Four-µm-thick sections were cut from paraffin-embedded tissues, stained with hematoxylin and eosin (H & E), and examined to obtain histologic findings such as depth of invasion, lymphatic and vascular permeations, and status of lymph node metastasis. The stage of the disease and operative curability were estimated, and the patients' outcomes and causes of death were examined. These clinicopathologic findings were investigated according to the Japanese classification of gastric carcinoma outlined by the Japanese Gastric Cancer Association [5] . Serosal invasion was defined as tumor involvement of the serosal surface or of the adjacent organs. Surgery was regarded as curative when the macroscopic tumor tissue was completely removed during surgery and histology showed the resection margin to be free of tumor cells.
Differences in clinicopathologic data between PGC and NGC were analyzed by the 2 test and Student's ttest. Survival rates were calculated using the KaplanMeier method and were assessed by the generalized Wilcoxon test. Multivariate analysis, by the Cox proportional hazards model, was performed to determine independent prognostic factors. A P value of less than 0.05 was regarded as statistically significant.
Results
Significant differences between PGC and NGC were seen in the frequency of patients over 65 years of age (68% vs 51%), tumor location in the upper one-third of the stomach (37% vs 19%), grossly localized type (85% vs 67%), negative serosal invasion (86% vs 73%), and occurrence of liver metastasis (14% vs 3%) ( Table 1) . Advanced PGC, compared with advanced NGC, was characteristically located in the upper one-third of the stomach (50% vs 25%) and grossly localized (74% vs 38%), with negative serosal invasion (76% vs 49%) and frequent liver metastasis (24% vs 5%). Early PGC, compared with early NGC, was frequently seen in patients over 65 years of age (74% vs 50%) and was the grossly elevated type (67% vs 21%). When 65 patients with PGC were compared with age-and sex-matched patients with NGC, the difference between the two groups was also significant in the tumor location and liver metastasis ( Table 2) .
The overall 5-year survival rate was significantly lower for patients with PGC than for patients with NGC (63% vs 76%) (Fig. 2) . When the same stage of disease was compared, however, the 5-year survival rates were not different between PGC and NGC ( Fig.  3) . Of 65 patients with PGC, 21 (32%) died of recurrence. Of these 21 patients, liver metastasis occurred in 13 (62%) and peritoneal dissemination in 1 (5%).
Clinicopathologic factors influencing the prognosis of patients with PGC were the type of gastrectomy, tumor size, gross appearance, serosal invasion, lymphatic and vascular permeations, lymph node metastasis, peritoneal dissemination, liver metastasis, stage of disease, and operative curability (Table 3) . Of these 11 factors, liver metastasis, serosal invasion, and lymph node metastasis independently affected the prognosis of patients with PGC (Table 4) .
Discussion
PGC is a rare histologic type among adenocarcinomas of the stomach. Recent Japanese reports showed that PGC accounted for only 6% to 11% of gastric carcinomas [6, 7] , and the incidence in our series (10%) was in accordance with these data. In this study, we clarified the clinicopathologic characteristics of PGC, which include occurrence in aged patients, proximal tumor location, gross appearance of an elevated type in the early stage and a localized type in the advanced stage, negative serosal invasion, frequent liver metastasis, and, ultimately, poor patient outcomes. Nakamura et al. [8] investigated the clinicopathologic findings of 7031 patients with gastric carcinoma and found that the histologic type did not influence the prognosis after gastrectomy, except in special types such as adenosquamous and squamous cell carcinomas [9, 10] . In their study, however, papillary adenocarcinoma was classified as well differentiated adenocarcinoma, and the prognostic value of PGC was not evaluated. Maruyama [11] undertook a multivariate analysis of 3994 patients who had gastric carcinoma without distant metastasis, and demonstrated that histologic type was one of five prognostic factors independently influencing the survival of patients.
In a Japanese report, Hirota et al. [7] indicated that when tumors were classified by the depth of wall metastasis in all tumors of 18%, 48%, and 62%, respectively. The 10-year survival rates in patients with papillary adenocarcinomas that invaded the submucosa, muscularis propria, and subserosa were 61%, 61%, and 33%, respectively, while the 10-year survival rates for all tumors were 76%, 70%, and 51%, respectively. These differences were significant. Hirota and colleagues [7] therefore concluded that, except for tumors limited to the mucosa and those invading down to the serosal surface, papillary adenocarcinoma was significantly correlated with a poor prognosis, because of its frequent lymph node metastasis. In our study, the difference in the frequency of lymph node metastasis between PGC (54%) and NGC (43%) was not significant. When mucosal cancers and cancers with serosal invasion were excluded, the frequency of lymph node metastasis was 65% in PGC (n ϭ 40) and 40% in NGC (n ϭ 265), which was a significant difference (P Ͻ 0.01). Our data, therefore, agree with the findings reported by Hirota and colleagues [7] . However, the 5-year survival rate of our patients with PGC (63%) was higher than that of their patients with PGC (47%). The frequency of serosal invasion in our series (14%) was significantly lower than that in their patients (40%) (P Ͻ 0.01). We consider that this difference in the frequency of serosal invasion correlated with the difference between the 5-year survival rate in our study and that reported by Hirota et al. [7] .
Liver metastasis and peritoneal dissemination are the most serious progressions of gastric carcinoma [12] . It is well documented that the former is most frequently Fig. 2 . Survival curves for 65 patients with papillary gastric carcinoma (PGC) and 566 patients with non-papillary gastric carcinoma (NGC) Fig. 3 . Survival curves for patients with papillary gastric carcinoma (PGC) and non-papillary gastric carcinoma (NGC), according to the stage of disease invasion, papillary adenocarcinoma was associated with frequent lymph node metastasis and a low survival rate. They divided 6276 gastric carcinomas into six histologic types: papillary adenocarcinoma (n ϭ 699), well differentiated tubular adenocarcinoma (n ϭ 1081), moderately differentiated tubular adenocarcinoma (n ϭ 1159), poorly differentiated adenocarcinoma (n ϭ 1628), mucinous adenocarcinoma (n ϭ 228), and signetring cell carcinoma (n ϭ 1481). The frequency of lymph node metastasis was highest in papillary adenocarcinoma, occuring in 32% of tumors invading the submucosa, 56% of those invading the muscularis propria, and 75% of those invading the subserosa, when compared with the frequencies of lymph node found in histologically well differentiated tumors, while the latter is often seen in poorly differentiated tumors [1] [2] [3] [4] 13] . Kaibara et al. [14] examined 71 patients with gastric carcinoma associated with synchronous or metachronous metastasis to the liver and showed that papillary adenocarcinoma was the most frequent histologic type (37%), followed by poorly differentiated adenocarcinoma with a medullary growth pattern (31%). They suggested that, as most papillary adenocarcinomas exhibited a medullary growth pattern, metastasis to the liver from gastric carcinoma was significantly associated with a medullary growth pattern, irrespective of the histologic type.
We previously investigated 74 patients with poorly differentiated medullary carcinoma of the stomach and showed that they were characterized by simultaneous or recurrent metastasis to the liver [15] . Because papillotubular differentiation in the mucosa of the tumor margin was seen in 28 tumors (38%), it was concluded that some of the poorly differentiated medullary carcinomas arose as papillary adenocarcinomas in the gastric mucosa. Our study also clarified the clinicopathologic factors influencing the prognosis of patients with PGC. On the univariate analysis, a poor outcome was associated with large tumor size, grossly infiltrative growth, and the presence of serosal invasion, lymphatic and vascular permeations, lymph node metastasis, peritoneal dissemination, and liver metastasis. However, multivariate analysis revealed that the most important prognostic factor was liver metastasis, followed by serosal invasion and lymph node metastasis. To improve the surgical outcome for PGC, preoperative and postoperative examinations for liver metastasis are important. When the histology of a biopsy specimen shows PGC, liver metastasis must be checked by ultrasonography and computed tomography prior to surgery [16, 17] . Even if liver metastasis is not detected and curative gastrectomy is carried out, we must remember that, in patients with PGC, there may be later recurrence in the liver, resulting in tumor-related death.
In conclusion, although PGC is a rare histologic entity among gastric carcinomas, its biologic behavior is characterized by occurrence in aged patients, proximal tumor location, frequent liver metastasis, and poor surgical outcome even after curative gastrectomy.
